Pathophysiology and management of Akathisia 70 years after the introduction of the chlorpromazine, the first antipsychotic

CONCLUSIONS: Pharmacological management may pose a challenge in chronic akathisia. Rotation between different pharmacological management strategies may be optimal in resistant cases. Discontinuation of the causative drug and use of b-blockers, mirtazapine, benzodiazepines or gabapentinoids for symptomatic relief is the basis of management.PMID:34337722 | DOI:10.26355/eurrev_202101_26386

Source: European Review for Medical and Pharmacological Sciences - August 2, 2021 Category: Drugs & Pharmacology Authors: N Zareifopoulos M Katsaraki P Stratos V Villiotou M Skaltsa A Dimitriou M Karveli P Efthimiou M Lagadinou D Velissaris Source Type: research